Metronidazole/neomycin/nystatin/prednisolone

Drug Profile

Metronidazole/neomycin/nystatin/prednisolone

Alternative Names: Tergynan

Latest Information Update: 10 Jun 2011

Price : $50

At a glance

  • Originator Recordati
  • Class Antibacterials; Antifungals; Corticosteroids
  • Mechanism of Action DNA synthesis inhibitors; Glucocorticoid receptor agonists; Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Vaginitis

Most Recent Events

  • 31 Dec 2010 Launched for Vaginitis in Ukraine before December 2010 (Vaginal)
  • 31 Dec 2010 Launched for Vaginitis in Commonwealth of Independent States before December 2010 (Vaginal)
  • 30 Sep 2005 Launched for Vaginitis in France before September 2005 (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top